Birx: FDA 'has been very clear' on its concerns about using hydroxychloroquine as COVID-19 treatment

France Nouvelles Nouvelles

Birx: FDA 'has been very clear' on its concerns about using hydroxychloroquine as COVID-19 treatment
France Dernières Nouvelles,France Actualités
  • 📰 USATODAY
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 63%

'It clearly shows the comorbidity that puts individuals at more risk,' Dr. Birx said of the new study, referring to patients with underlying health conditions.

a related drug, for COVID-19 treatment outside of hospitals or clinical trials due to the risk of life-threatening heart problems. Hydroxychloroquine is FDA-approved to treat or prevent malaria as well as autoimmune conditions such as lupus and rheumatoid arthritis.had a higher risk of death than those who were not given the drug.

The study comprises of 96,000 coronavirus patients from six different countries who were hospitalized between Dec. 20 and April 14. Nearly 15,000 patients were treated with hydroxychloroquine or chloroquine alone or in combination with an antibiotic "I think it was one of our clearest studies because there were so many thousands – tens of thousands – of individuals involved that the doctors clearly annotated who had heart disease and who had obesity, and you can see dramatically the increased risks for that."

The president had touted hydroxychloroquine for weeks, frequently discussing anecdotal evidence of its impact from the podium during White House briefings. His administration stockpiled 29 million doses of the drug earlier in the pandemic.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

USATODAY /  🏆 100. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

FDA investigates lab as tens of thousands of COVID-19 test results in Florida are questionedFDA investigates lab as tens of thousands of COVID-19 test results in Florida are questionedFederal regulators are investigating a Texas laboratory that a Florida hospital chain dropped last week because of delayed and unreliable COVID-19 test results.
Lire la suite »

FDA investigates lab as tens of thousands of COVID-19 test results in Florida are questionedFDA investigates lab as tens of thousands of COVID-19 test results in Florida are questionedThe dispute is expected to affect testing across the U.S. and also raises questions about how regulators and hospitals approve and choose labs.
Lire la suite »

With social distance safety warnings, Birx tempers Trump's reopening messageWith social distance safety warnings, Birx tempers Trump's reopening messageDeborah Birx told Americans they can start venturing out more Memorial Day weekend. But she stressed the importance of public health precautions and social distancing measures, coming at odds with Trump's more optimistic messaging.
Lire la suite »

'This is a bad practice': Doctors question FDA protocol for plasma treatment of coronavirus patients'This is a bad practice': Doctors question FDA protocol for plasma treatment of coronavirus patientsThe story of convalescent plasma is one of a federal medical establishment wanting badly to compensate for its slow response to the coronavirus.
Lire la suite »

Dr. Birx says states seeing 'dramatic decline' in percent of coronavirus positive cases as reopening gets underwayDr. Birx says states seeing 'dramatic decline' in percent of coronavirus positive cases as reopening gets underwayBrix said there have been 'significant declines week over week' in new COVID-19 cases, while outlining which metro areas have yet to see a decrease in cases.
Lire la suite »



Render Time: 2025-03-10 18:16:18